2020 Archives - Biocryst

Hereditary Angioedema Patients Would Prefer Newer-Generation Oral Prophylaxis

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)
Oral Once-Daily Berotralstat for the Prevention of Hereditary Angioedema Attacks: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)
Androgen Use in Hereditary Angioedema: A Critical Appraisal and Approaches to Transitioning from Androgens to Other Therapies

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)
Oral Berotralstat for the Prophylaxis of Hereditary Angioedema Attacks in Patients in Japan: A Phase 3 Randomized Trial

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)
Patient-reported burden of hereditary angioedema: findings from a patient survey in the United States

View Article

biocryst

January 27, 2025

Hereditary Angioedema (HAE)
Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence

View Article

biocryst

January 27, 2025

Hereditary Angioedema (HAE)
Hereditary angioedema: Epidemiology and burden of disease

View Article

biocryst

January 27, 2025

Hereditary Angioedema (HAE)
Hereditary Angioedema

View Article

biocryst

January 27, 2025

Hereditary Angioedema (HAE)
Kallikreins: Essential epidermal messengers for regulation of the skin microenvironment during homeostasis, repair and disease

View Article

biocryst

January 27, 2025

Netherton Syndrome (NS)
Advances in understanding of Netherton syndrome and therapeutic implications

View Article

biocryst

January 27, 2025

Netherton Syndrome (NS)